Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Angola

Angola

The Treatment of Cardiovascular Diseases market in Angola is expected to witness a significant growth in revenue.
By 2024, it is projected to reach a staggering US$202.80m, with an annual growth rate of 4.46%.
This growth trajectory is expected to continue until 2029, resulting in a market volume of US$252.20m.
When compared globally, United States is anticipated to generate the highest revenue in this market.
In 2024 alone, United States is projected to generate a remarkable US$136.00bn.
Angola has witnessed a growing demand for advanced cardiovascular treatments, leading to an increase in the availability of specialized medical facilities and expertise.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.